TB Treatment: Targeting Human Defenses

The fight against tuberculosis (TB) is getting an upgrade. Traditional treatments rely on antibiotics, but limitations like lengthy regimens and growing drug resistance are pushing research towards a new frontier: the human body's defenses.This innovative approach focuses on empowering our immune system to take down TB. By stimulating immune cells, researchers aim to equip them to effectively target and eliminate infected bacteria. Vaccines are under development to prime the immune system for a stronger response, while immunomodulatory drugs are being investigated to enhance the body's natural TB control mechanisms.This shift in strategy holds promise for a more effective and streamlined treatment. Shorter durations, reduced risk of resistance, and potentially fewer side effects could revolutionize TB management. This exciting new direction represents a significant step forward in controlling this global health threat